News Nutriband Lead Product Aversa(TM) Fentanyl May Reach Peak Annual Sales of $80-200 Million Based on Market Assessment by Leading Healthcare Consulting Firm Read More » January 5, 2022 News Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its “Abuse and Misuse Deterrent Transdermal System” Application Read More » December 31, 2021 News Nutriband Inc. Announces $1 Million Share Repurchase Authorization Read More » December 29, 2021 News Nutriband Inc. initiates plans to offer Topical lotion contract manufacturing services Read More » December 21, 2021 News Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary Read More » December 13, 2021 News Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021 Read More » December 3, 2021 News Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) Fentanyl Read More » November 16, 2021 News Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report® Read More » November 10, 2021 News Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch Read More » October 12, 2021 « Previous Page1 Page2 Page3 Page4 Page5 Next »
News Nutriband Lead Product Aversa(TM) Fentanyl May Reach Peak Annual Sales of $80-200 Million Based on Market Assessment by Leading Healthcare Consulting Firm Read More » January 5, 2022
News Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its “Abuse and Misuse Deterrent Transdermal System” Application Read More » December 31, 2021
News Nutriband Inc. Announces $1 Million Share Repurchase Authorization Read More » December 29, 2021
News Nutriband Inc. initiates plans to offer Topical lotion contract manufacturing services Read More » December 21, 2021
News Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary Read More » December 13, 2021
News Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021 Read More » December 3, 2021
News Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) Fentanyl Read More » November 16, 2021
News Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report® Read More » November 10, 2021
News Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch Read More » October 12, 2021